Gmel, G., Kuendig, H., Notari, L., & Gmel, C. (2015). Suchtmonitoring Schweiz : Konsum von Alkohol, Tabak und illegalen Drogen in der Schweiz im Jahr 2014 (Sucht Schweiz, Ed.). Lausanne: Sucht Schweiz.
Keywords: report; monitoring; consumption; alcohol; tobacco product; illegal drug use; cannabis; amphetamins; cocaine; heroin; ecstasy
|
Mission interministerielle de lutte contre la drogue et la toxicomanie, Direction générale du travail, Institut national de recherche et de sécurité, Hassé-Consultants, & Wallco (Eds.). (2012). Repères pour une politique de prévention des risques liés à la consommation de drogues en milieu professionnel. Lyon: La Documentation française.
Keywords: AOD use, abuse, and dependence; illegal drug use; alcohol; prevention; work; France
|
Insulza, J. M., & of American States, O. (2013). The drug problem in the Americas (A. Briones, F. Cumsille, A. Henao, & B. Pardo, Eds.). Washington; Bogotà: Organization of American States (OAS).
Keywords: health; epidemiology; AOD use, abuse, and dependence; chemical addiction; marijuana in any form; heroin; cocaine; psychoactive substances; amphetamines; designer drug; AOD consumption; AOD effects and AODR problems; AODR crime; violence; drug trafficking; drug dealing; AOD supply; illicit drug sales; illicit drug industry; AOD public policy strategy; law enforcement; drug decriminalization; international area; United States
|
Organization of American States. (2013). Scenarios for the drug problem in the Americas 2013-2025. Washington: Organization of American States (OAS).
Keywords: AOD use, abuse, and dependence; government and politics; public policy on AOD; illicit drug; drug market; AODR crime; AODR violence; strategy; cooperation; international area; United States
|
Osservatorio europeo delle droghe e delle tossicodipendenze. (2006). Relazione annuale 2006 : evoluzione del fenomeno della droga in Europa. Relazione annuale. Lussemburgo: Ufficio delle pubblicazioni ufficiali delle Comunità europee.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
Observatoire européen des drogues et des toxicomanies. (2006). Rapport annuel 2006 : état du phénomène de la drogue en Europe. Luxembourg: Office des publications officielles des communautés européennes.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
European Monitoring Centre for Drugs and Drug Addiction. (2006). Annual report 2006 : the state of the drugs problem in Europe. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
Europäische Beobachtungsstelle für Drogen und Drogensucht. (2006). Jahresbericht 2006 : Stand der Drogenproblematik in Europa. Jahresbericht. Luxemburg: Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
European Monitoring Centre for Drugs and Drug Addiction. (2005). Annual report 2005 : selected issues. Selected issues. Luxembourg: Office for Official Publications of the European Communities.
Abstract: This Selected issue is not intended to present a systematic and exhaustive review either of all possible definitions of drug-related public nuisance or of all measures, provisions and policies aimed at reducing the problem in the European Union, nor does it aim to reflect precisely the situation regarding public nuisance in each of the countries concerned. Rather, it seeks to contribute to our understanding of the issues and problems related to a new – and somewhat still limited – area for intervention in Member States, candidate countries and Norway. This document aims to present the first EMCDDA qualitative insight into an emerging concern within drug policy debate, at both national and European levels. The alternatives to prison that may be offered to drug-using offenders cover a range of sanctions that may delay, avoid, replace or complement prison sentences for those drug users who have committed an offence normally sanctioned with imprisonment by national law. In this Selected issue, the focus is on those measures that have a drug-related treatment component. It will describe the political and legal background, the application and implementation, including common problems, and the effects of treatment as an alternative to imprisonment. Since the mid-1990s buprenorphine has increasingly become available in Europe as an alternative to methadone for the treatment of opiate dependence. In this Selected issue, the reasons why clinicians are attracted to this drug, as well as the costs and benefits of buprenorphine in comparison with other treatment options, are explored in detail, and, for the first time, the increasing popularity of buprenorphine for the treatment of opiate dependence in many European countries is documented.
Keywords: government and politics; international area; Europe
|
Osservatorio europeo delle droghe e delle tossicodipendenze. (2005). Relazione annuale 2005 : evoluzione del fenomeno della droga in Europa. Relazione annuale. Lussemburgo: Ufficio delle pubblicazioni ufficiali delle Comunità europee.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
